RMD vs SYK
Resmed Inc (RMD) and Stryker Corp (SYK) are both filed with the SEC under Surgical & Medical Instruments & Apparatus. SYK is 3.6× RMD's size by market cap ($123.6B against $34.0B); SYK trades at the higher fiscal-year P/E (38.3× against 24.8×); RMD reports the higher net margin (27.2% against 12.9%); RMD grew sales faster over three years (+11.9% against +10.8%); and over the past year RMD returned -12.1% against SYK's -14.3%.
| RMD | SYK | |
|---|---|---|
| Last close | $240.33 | $330.69 |
| Market cap | $34.0B | $123.6B |
| P/E (FY) | 24.8× | 38.3× |
| P/S | 6.6× | 4.9× |
| EV/EBITDA | 17.6× | 21.0× |
| Gross margin | 59.4% | 64.0% |
| Operating margin | 32.7% | 19.5% |
| Net margin | 27.2% | 12.9% |
| Return on equity | 25.9% | — |
| Sales growth (3y) | +11.9% | +10.8% |
| EPS growth (3y) | +21.5% | +10.8% |
| Dividend yield | 0.9% | 1.0% |
| 1-year return | -12.1% | -14.3% |
Screener snapshot — prices as of 2026-08-28. Each side's last close is the most recent session the snapshot holds for that company, which can be an earlier one, and its 1-year return is measured to that close. Market caps struck on 2026-08-27. Last close, market cap and the 1-year return are price figures; every other row is computed over the company's latest filed fiscal year, and the two differ: RMD FY2025 (ended 2025-06-30); SYK FY2025 (ended 2025-12-31). — not published for this company. A ratio goes unpublished for more than one reason: a component the calculation needs is not on file, the filing does not tag the line it is read from, or the calculation is not defined on the filed basis — EV/EBITDA is not printed on non-positive EBITDA, and return on equity is not computed on a zero or negative equity base.
Who holds them, and who has traded them
| RMD | SYK | |
|---|---|---|
| Institutional holders (13F) | 933 | 2,276 |
| Insider buyers − sellers (180d) | -3 | -3 |
| Congressional trades disclosed (180d) | 1 | 3 |
| Executive-branch officials on file — trades disclosed (180d) | 9 | 15 |
Counts only. The congressional figures count transactions dated in the trailing 180 days and disclosed in STOCK Act periodic transaction reports; amounts are filed as ranges and are never summed. The executive-branch figures count the same window of transactions, and they are scoped to one roster. The officials OGE posts for direct download. Insider buyers − sellers counts distinct people filing open-market Form 4 purchases minus distinct people filing open-market sales over the trailing 180 days, capped at ±5.
RMD vs SYK: common questions
- Is RMD bigger than SYK?
- SYK carries the larger market cap — $123.6B against $34.0B, both struck on 2026-08-27.
- Which trades at a higher P/E, RMD or SYK?
- SYK, at a fiscal-year 38.3× against 24.8× for RMD. Both are price ÷ latest full-year diluted earnings per share, not a trailing-twelve-month P/E.
- How have RMD and SYK performed over the past year?
- RMD returned -12.1% and SYK -14.3%, measured on the trailing calendar year to the last close.
- How many institutions hold RMD and SYK?
- 933 13F filers report a position in RMD and 2,276 in SYK, on the latest quarter in the panel.
- Are RMD and SYK in the same industry?
- Both are filed with the SEC under Surgical & Medical Instruments & Apparatus, which is the classification this pairing is built on.
RMD overview → · SYK overview → · RMD institutional ownership → · SYK institutional ownership → · Congress and RMD → · Congress and SYK → · Executive branch and RMD → · Executive branch and SYK →
More in Surgical & Medical Instruments & Apparatus: BDX vs BSX · BDX vs DXCM · BDX vs MMM · BDX vs RMD
Stock comparisons lists every pair this site publishes.
Source: SPZCO — https://spzco.com/vs/rmd-vs-syk